Skip to contentP
Precision Biosciences Inc
P
DTILPrecision Biosciences Inc Q2 2022 · 10-Q
Revenue$3.82M$3.82M−94.4% vs Q2 2021 Net Income-$31.04M-$31.04MN/M vs Q2 2021 EPS Diluted-$0.46-$0.46N/M vs Q2 2021 Operating Income-$29,554,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Precision Biosciences Inc · CIK 1357874 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$25,003,000N/M Margins · derivedOperating margin-773.7%−805.1 pt vs Q2 2021
Net margin-812.4%−843.9 pt vs Q2 2021
ended Jun 30, 2022 · filed Aug 8, 2022 · 39 d after period end